Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mary Nwangwu"'
Autor:
Joo Y. Song, Mary Nwangwu, Ting-Fang He, Weiwei Zhang, Hany Meawad, Victoria Bedell, Joyce Murata-Collins, Pamela Skrabek, Michel R. Nasr, David Scott, James Godfrey, Peter Lee, Wing C. Chan, Dennis D. Weisenburger, Anamarija M. Perry, Alex F. Herrera
Publikováno v:
Haematologica, Vol 108, Iss 8 (2023)
The tumor microenvironment (TME) is important in the pathogenesis and prognosis of lymphoma. Previous studies have demonstrated that features of the diffuse large B-cell lymphoma (DLBCL) TME can be associated with prognosis, but questions remain abou
Externí odkaz:
https://doaj.org/article/30156ee0a56e4fd5ba6abfb1984ba789
Autor:
Alex F Herrera, Lu Chen, Yago Nieto, Leona Holmberg, Patrick Johnston, Matthew Mei, Leslie Popplewell, Saro Armenian, Thai Cao, Leonardo Farol, Firoozeh Sahebi, Ricardo Spielberger, Robert Chen, Auayporn Nademanee, Sandrine Puverel, Mary Nwangwu, Peter Lee, Joo Song, Alan Skarbnik, Neena Kennedy, Lacolle Peters, Steven T Rosen, Larry W Kwak, Stephen J Forman, Tatyana Feldman
Publikováno v:
The Lancet Haematology. 10:e14-e23
Autor:
Matthew G. Mei, Hun Ju Lee, Joycelynne M. Palmer, Robert Chen, Ni-Chun Tsai, Lu Chen, Kathryn McBride, D. Lynne Smith, Ivana Melgar, Joo Y. Song, Kimberley-Jane Bonjoc, Saro Armenian, Mary Nwangwu, Peter P. Lee, Jasmine Zain, Liana Nikolaenko, Leslie Popplewell, Auayporn Nademanee, Ammar Chaudhry, Steven Rosen, Larry Kwak, Stephen J. Forman, Alex F. Herrera
Publikováno v:
Blood. 139(25)
This phase 2 trial evaluated PET-adapted nivolumab alone or in combination with ifosfamide, carboplatin, and etoposide (NICE) as first salvage therapy and bridge to autologous hematopoietic cell transplantation (AHCT) in relapsed/refractory (RR) clas
Autor:
Colt Egelston, Robert Zhang, Min Hui Lim, Kena Ihle, Zhen Han, Eliza R. Bacon, Diana L. Simons, Daniel Schmolze, Jian Ye, Mary Nwangwu, Peter P. Lee, Shawn Solomon, Lei Wang, Christian Avalos, James Waisman, Weihua Guo, Jiayi Tan
Publikováno v:
Journal of Clinical Oncology. 38:1032-1032
1032 Background: Immune composition in the tumor microenvironment (TME) of patient tumors has proven to play a central role in the propensity of tumors to metastasize and respond to therapy. Evidence has suggested that the metastatic TME is immune ab
Autor:
Jiayu Liao, Mary Nwangwu
Publikováno v:
Nwangwu, Mary; & Liao, Jiayu. (2018). Determination of Immune Signal–Receptors, PD-1 and PD-L1, Interactions in Solution using qFRET Technology. UC Riverside Undergraduate Research Journal Submit, 12(1). Retrieved from: http://www.escholarship.org/uc/item/2d09435x
Author(s): Nwangwu, Mary; Liao, Jiayu | Abstract: Human PD-L1 (programmed cell death 1 - ligand 1) is a transmembrane protein that is highlyexpressed on the membrane of cancer cells. It binds to inhibitory receptor PD-1 (programmed celldeath protein